🚨Tomorrow evening @ 6 PM Eastern: See the latest work from the next generation of neurogastroenterology research stars ANMS Yuying Luo naomi tjaden, md, phd Jacques Gonzales Amy Shepherd

us06web.zoom.us/webinar/regist…

Amazing for our ANMS counsel member to have achieved all this!! ACG Elyse R. Thakur Kyle Staller, MD, MPH Greg Sayuk, MD, MPH 🤩leila 😍👏 Amazing mentor to many and incredible clinician!

Delighted to announce that the atlantis_trial of low-dose titrated amitriptyline as a second-line treatment for #IBS in primary care is now published online in The Lancet

authors.elsevier.com/sd/article/S01…

I will be presenting the results today at 1430hrs at #UEGWeek2023

'Antibiotic use as a risk factor for irritable bowel syndrome: Results from a nationwide, case–control study' - read at bit.ly/3tiSKGF. .
#IBS #GITwitter

A lot is happening ANMS YIF with fresh ideas for research in many areas of #DGBIs & #NGM Rome Foundation #DrWolfson #DrLi #DrSpencer #AShepherd #DrDavis #DrMajd #JGonzales #DrCarson 👏👇🏽Kyle Staller, MD, MPH Greg Sayuk, MD, MPH Rajan Singh

#GITwitter , help us welcome the newest AGA Institute Council members! 🥳 Doug Robertson, Braden Kuo, Arianne Theiss, Sandeep K. Gupta, Sonia Kupfer, Raman Muthusamy and C. Prakash Gyawali will help lead AGA's programming at next year’s Digestive Disease Week ow.ly/zgJO50OGN7n

📌Aprepitant is safe & effective prophylactic med in adults w/ refractory cyclic vomiting syndrome. 71% of pts w/ significant ⬇️ in # of CVS episodes, ED visits & hospitalizations. Adequate insurance coverage is a major barrier preventing its use.

▶️bit.ly/41uGRJK

Very happy to share our labor of love on care for this very stigmatized group of patients Helen Burton Murray, Ph.D. Sophie Abber, M.S.

Douglas Drossman MD & I had the pleasure of facilitating a Train the Trainer this weekend in effective communications w/these amazing clinicians & emerging leaders in #GI . Between the learning we had a lot of laughs & cemented friendships. The future of neurogastro is bright! 💩

📌Pts w/ #DGBI & comorbid #anxiety are less likely to respond to any medication, including neuromodulators, prescribed for their GI symptoms

Read more in February's Neurogastro & Motil:
▶️bit.ly/3KqVPvd

The challenge of chronic abdominal pain can be tackled with a thoughtful approach emphasizing patient education and treatment over testing. gastroendonews.com/PRN/Article/02… ACG Kyle Staller, MD, MPH MGH Division of Gastroenterology #chronicpain

A new study found that NP-delivered #CBT was feasible, acceptable, and showed clinical improvements in #IBS symptom severity and #QOL in a cohort of 25 IBS patients.

Great job to the authors Helen Burton Murray, Ph.D. Laurie Keefer, PhD Kyle Staller, MD, MPH

onlinelibrary.wiley.com/doi/full/10.11…

Join us on Feb 24-25 at the 4th Annual Live Medical Crossfire: #IBS and #IBD !

With co-chairs Anita Afzali MD, MPH, MHCM, FACG, AGAF Bruce E. Sands William Chey, we'll be discussing many hot topics, and I'lll be speaking on #malignancy in IBD!

**FREE** registration with code AXELRAD bit.ly/3IUk1oI

How does psychiatric comorbidity affect #DGBI Mx?

🇺🇸Study showed
Most common psy:Anxiety disorders(35%)
Pts with #Anxiety 😨 less likely to respond to neuromodulators or any GI medication.

🧐Early psychological intervention is 🔑

onlinelibrary.wiley.com/doi/10.1111/nm…
#GITwitter #MedTwitter

Thank you NEJM NEJMCPC for shining a light on stomach cancer, especially diffuse type disease. Anything to raise awareness helps.

Case 31-2022: A 72-Year-Old Man with Heartburn, Nausea, and Inability to Eat | NEJM nejm.org/doi/full/10.10…

My Fav Oral Abstract #UEGW2022 by Helen Burton Murray, Ph.D. shows ABDOMINAL PAIN was at the core of the global symptom network and for pathways connecting DGBI diagnostic categories.
programme.ueg.eu/week2022/#/det…

#DGBI #MyUEGcommunity #GItwitter #pain